Ipsen
| Use attributes for filter ! | |
| Stock price | IPN |
|---|---|
| Disclaimer | |
| Headquarters | Paris |
| France | |
| Ceo | David Meek |
| Number of employees | 5,700 |
| Subsidiaries | Linnea SA |
| OctreoPharm Sciences GmbH | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 883976 |
About Ipsen
Ipsen is a French pharmaceutical company headquartered in Paris, France. It develops and markets medications used in oncology, neuroscience and rare diseases along with consumer healthcare products. It is publicly traded on the Euronext Paris as part of the SBF 120 index. Ipsen has about 5,700 employees worldwide.
